Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04267939
Title ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

Advanced Solid Tumor

Therapies

BAY1895344 + Niraparib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
Memorial Sloan-Kettering Cancer Center Recruiting New York New York 10065 United States Details
Cleveland Clinic Foundation Withdrawn Cleveland Ohio 44195 United States Details
University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field